Advarra, the premier provider of institutional review board (IRB), institutional biosafety committee (IBC), and research quality and compliance consulting services, is pleased to announce the intent to acquire Forte, the industry's leading provider of standards-based clinical research technology solutions for major academic medical centers, cancer centers, and health systems